The fund is generally included in 2-6 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Video, Health Care. Among the most popular portfolio startups of the fund, we may highlight Sense Biodetection, Voxpopme.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Mercia Asset Management, startups are often financed by Upscale, Mercia Technologies, Mercia Fund Managers. The meaningful sponsors for the fund in investment in the same round are Origin Ventures, NVM Private Equity, Jonathan Milner. In the next rounds fund is usually obtained by Innovate UK.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 5square | Laren, Noord-Holland, The Netherlands |
| Banca Sella Group | Biella, Italy, Piemonte |
| Beijing Qianyi Investment Center | Beijing, Beijing Shi, China |
| Comcast Spectacor | Pennsylvania, Philadelphia, United States |
| Foot Locker | New York, New York, United States |
| Global Digital Niaga | - |
| Indian Designs Group | - |
| Integral Wealth Securities Limited | California, Ontario, United States |
| Karur Vysya Bank | India, Karur, Tamil Nadu |
| KMS Technology | Atlanta, Georgia, United States |
| Lanying Information Technology | China, Guangdong, Shenzhen |
| Lorem Partners | Alberta, Calgary, Canada |
| Meruelo Capital Partners | California, Downey, United States |
| Money Partners Group | Japan, Tokyo |
| NTT Plala | Japan, Toshima |
| OperatorVC | Ghaziabad, India, Uttar Pradesh |
| The Higher Education Emergency Relief Fund II | - |
| Walden Israel Venture Capital | HaMerkaz, Israel, Petah Tiqva |
| Westway Capital | Connecticut, United States, Westport |
| Yun Chou Shiliuhao Touzi | China, Guangdong, Zhuhai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Newcells Biotech | 16 Mar 2023 | Newcastle upon Tyne, England, United Kingdom | |||
HowNow | $5M | 06 Feb 2023 | London, England, United Kingdom | ||
Flabba | $548K | 31 Oct 2022 | Bournemouth, Bournemouth, United Kingdom | ||
Cloud8 | $1M | 28 Mar 2022 | Bristol, England, United Kingdom | ||
Forensic Analytics | $6M | 28 Oct 2021 | Letchworth, East, United Kingdom | ||
Citizenme | $2M | 25 Oct 2021 | London, England, United Kingdom | ||
| $50M | 20 Apr 2021 | Vale of White Horse, England, United Kingdom | |||
Newcells Biotech | $6M | 24 Feb 2021 | Newcastle upon Tyne, England, United Kingdom | ||
Oto Health | 23 Feb 2021 | London, England, United Kingdom |
– Forensic Analytics is a digital forensics company based in Letchworth, Hertfordshire, UK.
– The company raised £4.5m in funding.
– The funding was led by Mercia Asset Management PLC via its own balance sheet and the Northern VCT Funds.
– The new investment will be used to further invest into its innovative cloud-based software platform and expand its sales internationally.
– Locate Bio is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by existing shareholder Mercia Asset Management and new investor BGF.
– The funding will be used to further advance Locate Bio’s proprietary pipeline of regenerative orthobiologics products towards patients, with key clinical and regulatory milestones expected to catalyse growth over the next two years.
– The investment brings the total funds raised by Locate Bio to over £18 million. The company’s lead product in development is called LDGraft, and is a low dose, controlled release rhBMP-2 for the treatment of degenerative disc disease.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Newcells Biotech | 16 Mar 2023 | Newcastle upon Tyne, England, United Kingdom | |||
HowNow | $5M | 06 Feb 2023 | London, England, United Kingdom | ||
Flabba | $548K | 31 Oct 2022 | Bournemouth, Bournemouth, United Kingdom | ||
Cloud8 | $1M | 28 Mar 2022 | Bristol, England, United Kingdom | ||
Forensic Analytics | $6M | 28 Oct 2021 | Letchworth, East, United Kingdom | ||
Citizenme | $2M | 25 Oct 2021 | London, England, United Kingdom | ||
| $50M | 20 Apr 2021 | Vale of White Horse, England, United Kingdom | |||
Newcells Biotech | $6M | 24 Feb 2021 | Newcastle upon Tyne, England, United Kingdom | ||
Oto Health | 23 Feb 2021 | London, England, United Kingdom |
